Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
Marguerite A. Butler(National Center for Toxicological Research), Fred F. Kadlubar(Courtauld Institute of Art), Richard B. Hayes(National Institutes of Health), Joyce Massengill(John L. McClellan Memorial Veterans Hospital), J.F. Young(Aarhus University), Candee H. Teitel(National Center for Toxicological Research), Nicholas P. Lang(John L. McClellan Memorial Veterans Hospital), Neil E. Caporaso(Department of Health and Human Services), P Vineis(University of Turin), M. F. Lawsen(University of Arkansas for Medical Sciences)
Cited by 418
Related Papers
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|Nature Genetics|2007|1.1k
Selection Criteria for Lung-Cancer Screening
|New England Journal of Medicine|2013|1k
Multiple loci identified in a genome-wide association study of prostate cancer
|Nature Genetics|2008|907
Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.
|Proceedings of the National Academy of Sciences|1989|638